Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
We created the first FDA-cleared device supports concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection.
Our four FDA-cleared applications are designed to improve reading efficiency and accuracy across the hospital enterprise without requiring additional hardware.
Riverain’s deep learning AI technology is FDA cleared, field tested, and clinically proven to provide real results in radiology.
Riverain Technologies advanced AI imaging software is in use by leading healthcare organizations around the world.
Peer reviews, reference accounts, and independent studies confirm that ClearRead technology is positively impacting the field of radiology.
We are happy to welcome Tom Maloney as our new Chief Financial Officer. He will be responsible for Riverain Technologies’ financial planning, risk management, information technology, human resources, and strategies to achieve business goals.
Maloney has over 25 years of experience in financial and operational performance. He has worked in a range of industries, including healthcare and international law. He has over 15 years of experience as an Executive, in both COO and CFO roles, including expertise in strategic planning, operations, capital projects, and financial reporting and forecasting.
He earned his B.S. in accounting and finance from Wright State University.